DE69927154T2 - Vorrichtung und verfahren zur behandlung von erektionsstörungen - Google Patents

Vorrichtung und verfahren zur behandlung von erektionsstörungen Download PDF

Info

Publication number
DE69927154T2
DE69927154T2 DE69927154T DE69927154T DE69927154T2 DE 69927154 T2 DE69927154 T2 DE 69927154T2 DE 69927154 T DE69927154 T DE 69927154T DE 69927154 T DE69927154 T DE 69927154T DE 69927154 T2 DE69927154 T2 DE 69927154T2
Authority
DE
Germany
Prior art keywords
amount
administration
therapeutic agent
prostaglandin
plasticizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69927154T
Other languages
German (de)
English (en)
Other versions
DE69927154D1 (de
Inventor
Spiros Fotinos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lavipharm Laboratories Inc
Original Assignee
Lavipharm Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22223792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69927154(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lavipharm Laboratories Inc filed Critical Lavipharm Laboratories Inc
Publication of DE69927154D1 publication Critical patent/DE69927154D1/de
Application granted granted Critical
Publication of DE69927154T2 publication Critical patent/DE69927154T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nursing (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Attitude Control For Articles On Conveyors (AREA)
DE69927154T 1998-06-25 1999-06-25 Vorrichtung und verfahren zur behandlung von erektionsstörungen Revoked DE69927154T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9067498P 1998-06-25 1998-06-25
US90674P 1998-06-25
PCT/US1999/014410 WO1999066870A1 (en) 1998-06-25 1999-06-25 A device and method for the treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69927154D1 DE69927154D1 (de) 2005-10-13
DE69927154T2 true DE69927154T2 (de) 2006-06-29

Family

ID=22223792

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927154T Revoked DE69927154T2 (de) 1998-06-25 1999-06-25 Vorrichtung und verfahren zur behandlung von erektionsstörungen

Country Status (11)

Country Link
EP (1) EP1089679B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002518417A (cg-RX-API-DMAC7.html)
AT (1) ATE303774T1 (cg-RX-API-DMAC7.html)
AU (1) AU765057B2 (cg-RX-API-DMAC7.html)
CA (1) CA2335736A1 (cg-RX-API-DMAC7.html)
DE (1) DE69927154T2 (cg-RX-API-DMAC7.html)
HU (1) HUP0103206A3 (cg-RX-API-DMAC7.html)
IL (2) IL140475A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ509031A (cg-RX-API-DMAC7.html)
PL (1) PL345087A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999066870A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
USRE42126E1 (en) 1999-07-02 2011-02-08 The Procter & Gamble Company Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
KR100402334B1 (ko) 2000-06-23 2003-10-22 환인제약 주식회사 알프로스타딜 외용제
ES2341090T3 (es) * 2000-08-30 2010-06-15 Unimed Pharmaceuticals, Llc Procedimiento para tratar la disfuncion erectil y aumentar la libido en hombres.
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6899897B2 (en) 2001-06-18 2005-05-31 Jaleva, Inc. Gum resin as a carrier for topical application of pharmacologically active agents
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
JP3874419B2 (ja) 2003-01-31 2007-01-31 三共株式会社 動脈硬化及び高血圧症の予防及び治療のための医薬
CN1787824A (zh) * 2003-06-25 2006-06-14 有限会社循环器研究所 性交功能改善用外用制剂
US9554984B2 (en) 2003-11-03 2017-01-31 Jaleva Pharmaceuticals, Llc Oral care compositions for topical application
CA2629810A1 (en) 2005-11-07 2007-05-18 Jaleva, Llc Film-forming resins as a carrier for topical application of pharmacologically active agents
IT201600119871A1 (it) * 2016-11-25 2018-05-25 Sabatino Russo Uso dell’associazione di inibitori della fosfodiesterasi 5 con prostaglandina e1 per il trattamento della disfunzione erettile

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
JPS61204117A (ja) * 1985-03-07 1986-09-10 Tooa Eiyoo Kk 経皮吸収外用剤
FI872552A7 (fi) 1986-06-09 1987-12-10 American Cyanamid Co Paikallisesti käytettävä prostaglandiinikoostumus.
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
SU1705319A1 (ru) * 1987-10-23 1992-01-15 Всесоюзный Научно-Исследовательский Институт Биотехнологии Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
IT1247678B (it) 1990-05-31 1994-12-28 Alberto Reale Metodo per la cura dell'impotenza erettiva maschile
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
DE4117249C2 (de) 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
DK0612521T3 (da) * 1991-11-11 2000-01-17 Hisamitsu Pharmaceutical Co Keterolacholdigt varmt omslag
ES2137261T3 (es) * 1992-05-13 1999-12-16 Alza Corp Administracion transdermica de oxibutinina.
JPH08510674A (ja) * 1993-05-28 1996-11-12 ヴェリケイド,インコーポレーテド 経皮血管拡張薬付きコンドーム
US5333621A (en) * 1993-05-28 1994-08-02 Eric Denzer Condom with transdermal vasodilator
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
AU713461B2 (en) * 1994-11-17 1999-12-02 Toray Industries, Inc. Preparation for percutaneous absorption
FR2729296B1 (fr) * 1995-01-12 1997-03-28 Europlanaire Compositions pharmaceutiques comprenant une superoxyde dismutase
US5741511A (en) * 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction
FR2748658B1 (fr) * 1996-05-15 2000-08-18 Biotec Centre Sa Utilisation de composes du type "alpha-bloquants" notamment le moxisylyte et/ou ses derives pour le traitement de dysfonctionnements erectiles par voie transmucosale balanique
ES2191834T3 (es) * 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.

Also Published As

Publication number Publication date
HUP0103206A2 (hu) 2002-05-29
DE69927154D1 (de) 2005-10-13
PL345087A1 (en) 2001-12-03
ATE303774T1 (de) 2005-09-15
IL140475A0 (en) 2002-02-10
EP1089679B1 (en) 2005-09-07
WO1999066870A1 (en) 1999-12-29
AU4720099A (en) 2000-01-10
HUP0103206A3 (en) 2002-11-28
EP1089679A1 (en) 2001-04-11
IL140475A (en) 2007-05-15
JP2002518417A (ja) 2002-06-25
NZ509031A (en) 2002-10-25
CA2335736A1 (en) 1999-12-29
AU765057B2 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
DE3779999T2 (de) Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
DE69217685T2 (de) Äusserliches auf der Haut anzuwendendes Lidocain enthaltendes Arzneimittel
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE3751383T3 (de) Feste Vorrichtungen zur transdermalen Wirkstoffabgabe, die Fettsäureester bzw. Fettalkoholether von Alkandiole als Absorptionsförderer verwenden.
DE69415535T2 (de) Verfahren zur regulierung der sexuellen reaktion beim menschen
DE102004016710B4 (de) Formulierung zur Fußpflege
DE69325495T2 (de) Extrudierbare Zusammensetzungen zur topischen oder transdermalen Wirkstoffabgabe
DE69836352T2 (de) Transdermales therapeutisches Pflaster mit Capsaicin und seinen Analogen
DE3856096T2 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
DE69825116T2 (de) Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler
EP2744474B1 (de) Medizinische hautschutz-zusammensetzung mit einer die hautbarriere verbessernden wirkstoffkombination
EP1029892A1 (de) Polysaccharid-, insbesondere paramylonenthaltendes gefriergetrocknetes Mittel, seine Herstellung und Verwendung
DE202015009503U1 (de) Haftender Folienverband für medizinische Kompression
DE10220230A1 (de) Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
WO2006120066A1 (de) Selbstklebende hautauflage und kombinationsset zur kosmetischen hautpflege
JPS60152413A (ja) メントールにより経皮性薬剤放出の強化を行なつた局所用組成物
DE1617780A1 (de) Heilmittel mit vernarbender Wirkung
EP1089679B1 (en) A device and method for the treatment of erectile dysfunction
DE69132743T2 (de) Transdermale Verabreichung an Menschen oder Tiere
DE10340428B4 (de) Opioides Analgetikum enthaltende transdermale Formulierung
EP2692332B1 (en) Composition for the treatment of callus, corns and psoriasis
US7087240B1 (en) Device and method for the treatment of erectile dysfunction
WO2007031364A1 (de) Verbandsmaterial mit wirkstoffen
DE2719770A1 (de) Ophthalmische pharmazeutische zubereitung mit langsamen freigabeeigenschaften unter verwendung von collagenen und verfahren zu deren herstellung
DE102004023984A1 (de) Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation